Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?
作者信息
McDonald Stephen, Reed Rachel, Baricevic-Jones Ivona, Ling Stephanie, Plant Darren, Barton Anne
机构信息
NIHR Manchester BRC, University of Manchester, Manchester, UK.
Kellgren Centre, Manchester University Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
出版信息
Rheumatology (Oxford). 2019 Oct 1;58(10):1872-1873. doi: 10.1093/rheumatology/kez147.
Abstract
摘要
相似文献
1
Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?血清白细胞介素-17和白细胞介素-10水平能否预测类风湿关节炎患者对生物治疗的反应？
Rheumatology (Oxford). 2019 Oct 1;58(10):1872-1873. doi: 10.1093/rheumatology/kez147.
2
Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data.生物制剂和非生物制剂抗风湿药物对 153788 例类风湿关节炎患者贫血标志物的疗效：真实世界数据的新证据。
Semin Arthritis Rheum. 2018 Feb;47(4):478-484. doi: 10.1016/j.semarthrit.2017.08.001. Epub 2017 Aug 3.
3
Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis.类风湿关节炎患者中扩大的自身抗体谱与生物治疗反应之间的关联。
Int Immunopharmacol. 2021 Feb;91:107260. doi: 10.1016/j.intimp.2020.107260. Epub 2020 Dec 23.
4
Change Over Time in the Pattern of Clinical Response to First-line Biologic Drugs in Patients with Rheumatoid Arthritis: Observational Data in a Real-life Setting.类风湿关节炎患者对一线生物药物临床反应模式随时间的变化：真实环境中的观察数据
J Rheumatol. 2017 Feb;44(2):262-263. doi: 10.3899/jrheum.161045.
5
Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study.生物制剂类改善病情抗风湿药物在老年类风湿关节炎患者中的安全性和有效性：一项前瞻性队列研究。
Drugs Aging. 2020 Dec;37(12):899-907. doi: 10.1007/s40266-020-00801-x. Epub 2020 Nov 18.
6
Use of biologic agents in rheumatoid arthritis: introduction.生物制剂在类风湿关节炎中的应用：引言
Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv3-4. doi: 10.1093/rheumatology/ker239.
7
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.2008年美国风湿病学会关于使用改善病情抗风湿药和生物制剂治疗类风湿关节炎的建议的2012年更新版。
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.
8
Switching of biologics in RA patients who do not respond to the first biologic.对第一种生物制剂无反应的类风湿关节炎患者更换生物制剂。
Joint Bone Spine. 2018 Jul;85(4):395-397. doi: 10.1016/j.jbspin.2018.02.001. Epub 2018 Feb 13.
9
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.美国风湿病学会2008年关于类风湿关节炎中使用非生物和生物改善病情抗风湿药物的建议。
Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721.
10
Adherence to biologic DMARD therapies in rheumatoid arthritis.类风湿关节炎中生物 DMARD 疗法的依从性。
Expert Opin Biol Ther. 2010 Sep;10(9):1367-78. doi: 10.1517/14712598.2010.510508.
引用本文的文献
1
Relation of Cytokine Profile and Antibody Values to Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis (Preliminary Data).类风湿关节炎患者细胞因子谱和抗体值与翻译后蛋白质修饰的关系（初步数据）
Dokl Biochem Biophys. 2025 May 11. doi: 10.1134/S1607672925700115.
2
IL-10/IL-10 receptor 1 pathway promotes the viability and collagen synthesis of pulmonary fibroblasts originated from interstitial pneumonia tissues.白细胞介素-10/白细胞介素-10受体1通路促进间质性肺炎组织来源的肺成纤维细胞的活力和胶原蛋白合成。
Exp Ther Med. 2022 Jun 15;24(2):518. doi: 10.3892/etm.2022.11445. eCollection 2022 Aug.
3
Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.增强的白细胞介素-10通过脓毒症中的信号转导和转录激活因子3信号通路抑制人脐静脉内皮细胞的增殖并促进其凋亡。
Histol Histopathol. 2021 Nov;36(11):1179-1187. doi: 10.14670/HH-18-375. Epub 2021 Sep 16.
4
Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.双盲随机对照试验，揭示巴西蜂胶摄入对类风湿关节炎疾病活动指数的影响；BeeDAI。
PLoS One. 2021 May 27;16(5):e0252357. doi: 10.1371/journal.pone.0252357. eCollection 2021.
本文引用的文献
1
Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints.白介素-10 家族细胞因子在类风湿关节炎中的表达：关节中 IL-19 水平升高。
Scand J Rheumatol. 2010 Mar;39(2):118-26. doi: 10.3109/03009740903170823.
2
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.白细胞介素-17在类风湿关节炎发病机制中的作用。
Curr Rheumatol Rep. 2009 Oct;11(5):365-70. doi: 10.1007/s11926-009-0052-y.
Zotero 插件